PRECISION: BLOOD CANCER
SEPTEMBER 18-19 2018
SAN FRANCISCO, USA
NETWORKING R&D SUMMIT
REGISTER
DOWNLOAD AGENDA
SCOPE OF THE MEETING
Blood Cancer accounts for 10% of new cancer cases diagnosed in the US in 2017. Approximately every 3 minutes one person is diagnosed and every 9 minutes one person dies.
Blood cancer R&D is experiencing rapid growth, representing an enormous opportunity for drug developers, driven by Innovative Cancer Treatment Therapies
The global market for Blood cancer therapeutics, valued at $24 billion in 2015, is poised to reach $38 billion by 2020, expanding by a CAGR of 9.7%
Do You Have the Latest Insights to Transform the Success of Your Pipeline?
Precision: Blood Cancer will bring together scientists and business leaders from pharma, biotech and academia, using extensive networking sessions to forge meaningful collaborations.
Discussions will revolve around translating the latest developments in the genomic and molecular understanding of the disease into new targeted therapies in the clinic.
HIGHLIGHTS
CAR-TCR
CHECKPOINT INHIBITORS
ANTIBODY CONSTRUCTS
BIOMARKERS
COMPANION DIAGNOSTICS
34%
26%
12%
12%
9%
7%
Large Drug Developers
Small & Mid-Sized Developers
Academia
& Hospitals
CROs &
Platform Technology
Equipment
Providers
Other
COMPANY TYPE
%
JOB TITLE
%
VP, Director, Head
C-Level
Scientists
Managers
48%
23%
18%
11%
GOALS OF THE EVENT
Learning Objectives
Target Audience
FEATURED SPEAKERS
New Speakers for 2018
JERRY ZELDIS
CMO
Sorrento Therapeutics
HANS-PETER GERBER
CSO and SVP
3T Biosciences
JONATHAN PACHTER
CSO
Verastem
CYRIL KONTO
Exec. Dir. Clinical Development
Allogene
JAGATH R. JUNUTULA
VP
Cellerant Therapeutics
KYLE MACBETH
Senior Director,
Translational Development & Dx
Celgene
DEVON J. SHEDLOCK
VP, Preclinical Development
Poseida Therapeutics
SELDA SAMAKOGLU
Director, Translational Medicine
Bristol-Myers Squibb
RONALD CHEUNG
Director, Clinical Development
Jazz Pharmaceuticals
PIETRO TAVERNA
Exec. Director, Translational medicine.
Sunesis Pharmaceuticals
TAE HAN
VP, Clinical Pharmacology & Translational Medicine
Amphivena Therapeutics
YANG PAN
Director, Biomarker Sciences
Gilead Sciences
VIEW AGENDA
DOWNLOAD PDF
DOWNLOAD OUR EVENT GUIDE
7 Pages Of Content, Produced In Collaboration With Our Advisory Board
TICKET OPTIONS
Choose The Correct Ticket - Group Rates Available
INDUSTRY DELEGATE
Standard rate: $2199
Pharma & Biotech Drug Developers / Solution Providers.
Access to 2-day Conference & Networking Sessions
$2199
(Limited Availability)
BUY NOW
ACADEMIC DELEGATE
Standard rate: $799
Reserved for Non-Profit Organizations.
Access to 2-day Conference & Networking Sessions
$799
(Limited Availability)
BUY NOW
SPONSORS
Our Event is Kindly Supported By:
MEDIA PARTNERS
Our Event is Kindly Supported By:
PREVIOUS EVENTS
VENUE
Our Event is Hosted at:
Crowne Plaza San Francisco Airport
1177 Airport Blvd, Burlingame, CA 94010, USA
DOWNLOAD EVENT GUIDE
Complete the form below to download the PDF
NEO SYNTH International House, 24 Holborn Viaduct, London EC1A 2BN
contact@neo-synth.com
(+1) 617.500.5172
Your details will not be shared with a third party
CONNECT!
Follow Our Latest News on Twitter
Copyright © 2018 | All content produced by: Neo-Synth Ltd.